CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,863 | $3.20 | $6K | 82,576 |
| 2025-01-02 | GROGAN DONNA ROY Director | Grant or award | +3,757 | $3.66 | $14K | 32,699 |
| 2025-01-02 | Anderson Kenneth Carl Director | Grant or award | +3,074 | $3.66 | $11K | 119,768 |
| 2024-11-19 | Hoerter Steven L. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-11-07 | Boyle Scott N Chief Business Officer | Option exercise | +3,750 | 57,669 | ||
| 2024-11-07 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 56,567 |
| 2024-11-07 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-11-07 | Adams Kendra Chief Financial Officer | Option exercise | +3,750 | 85,541 | ||
| 2024-11-07 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 84,439 |
| 2024-11-07 | Adams Kendra Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-11-07 | Schick Kelly Chief People Officer | Option exercise | +3,750 | 57,590 | ||
| 2024-11-07 | Schick Kelly Chief People Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 56,488 |
| 2024-11-07 | Schick Kelly Chief People Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-11-07 | Siegel Jolie Chief Legal Officer | Option exercise | +3,750 | 57,590 | ||
| 2024-11-07 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 56,488 |
| 2024-11-07 | Siegel Jolie Chief Legal Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-11-07 | Hirsch Andrew President & CEO | Option exercise | +12,500 | 227,412 | ||
| 2024-11-07 | Hirsch Andrew President & CEO | Shares withheld for taxes | −5,550 | $6.04 | $34K | 221,862 |
| 2024-11-07 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −12,500 | 35,000 | ||
| 2024-10-28 | Mahaney Paige Chief Scientific Officer | Grant or award | +76,800 | 76,800 |
Page 6 of 27 · 525 trades